Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Pulmatrix, Inc. Director's Dealing 2017

Mar 22, 2017

35037_dirs_2017-03-22_0a31065d-9fe6-418f-860a-304691f27bd5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulmatrix, Inc. (PULM)
CIK: 0001574235
Period of Report: 2017-03-20

Reporting Person: GILLIS STEVEN (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-03-20 Stock Option (Right to Buy) $2.78 A 4400 Acquired 2027-03-20 Common Stock (4400) Direct

Footnotes

F1: The option vests as to 25% on March 20, 2018 and the remaining 75% vests in thirty-six (36) equal monthly installments with 2.083% for each of the next thirty-six (36) months that follow March 20, 2018, subject to the terms and conditions of the Pulmatrix, Inc. Amended and Restated 2013 Employee, Director and Consultant Equity Incentive Plan.